Propolis Extract, Nanovitamin C and Nanovitamin E in Peri-implant Mucositis
Effect of Propolis Extract, Nanovitamin C and Nanovitamin E in Clinical and Microbiological Parameters of Peri-implant Mucositis: A Double-blind, Randomized, Clinical Trial
1 other identifier
interventional
46
1 country
1
Brief Summary
The objective of this study was to perform the first clinical trial to evaluate the effectiveness of propolis extract, nanovitamin C and nanovitamin E gel as adjuvant to mechanical debridement in clinical and microbiological parameters of implants with peri-implant mucositis
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 25, 2019
CompletedFirst Submitted
Initial submission to the registry
December 21, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 21, 2019
CompletedFirst Posted
Study publicly available on registry
January 2, 2020
CompletedJanuary 2, 2020
December 1, 2019
1.5 years
December 21, 2019
December 31, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in bleeding on probing
It was present when it appeared bleeding at the gingival margin after recording probing depths at six sites in each implant. Modified bleeding index was also collected.
baseline and 1-month follow-up
Secondary Outcomes (3)
Changes in probing depth
baseline and 1-month follow-up
Changes in plaque index
baseline and 1-month follow-up
Changes in microbilogical sample
baseline and 1-month follow-up
Study Arms (2)
Test group
EXPERIMENTALGel contained in tubes with the same appearance (30g), identical in colour, flavour and density, with the following components: Sodium-Monofluorophosphate, Silicon Dioxide, Glycerin, D-sorbitol, Polyethylene glycol, Sodium Carboxymethylcellulose, Xylitol, Sterol Glycoside, Peppermint Oil, L-Menthol, Methyl Hydroxybenzoate, Deionized Water, Propolis Extract (2%), Ascorbic Acid (0.2%) and Tocopherol Acetate (0.2%).
Placebo group
PLACEBO COMPARATORGel contained in tubes with the same appearance (30g), identical in colour, flavour and density, with the following components: Sodium-Monofluorophosphate, Silicon Dioxide, Glycerin, D-sorbitol, Polyethylene glycol, Sodium Carboxymethylcellulose, Xylitol, Sterol Glycoside, Peppermint Oil, L-Menthol, Methyl Hydroxybenzoate, Deionized Water and E155/151 coloring.
Interventions
The patient had to use the gel as a toothpaste and apply it with an interdental brush in mesial and distal aspects of the implant with peri-implant mucositis. during 1 month.
The patient had to use the gel as a toothpaste and apply it with an interdental brush in mesial and distal aspects of the implant with peri-implant mucositis.
Eligibility Criteria
You may qualify if:
- cooperative adult patients,
- with one or more implants with peri-implant mucositis, and
- presenting at least 18 months of functional loading.
You may not qualify if:
- refuse to participate in the study,
- patients who had implants with peri-implantitis (BOP and/or suppuration together with progressive radiographic marginal bone loss),
- patients with uncontrolled periodontitis (presence of nine or more sites with PD ≥ 5 mm and with full-mouth bleeding score (FMBS) \> 25%),
- systemic diseases or conditions that could alter the results of the study (diabetes mellitus, immunosuppression, infectious diseases, rheumatoid disease, history of bisphosphonate treatment, radiotherapy, chemotherapy, etc.),
- patients who had taken local and/or systemic antibiotics less than 2 months ago,
- pregnant or breastfeeding women, and
- patients with history of allergies to the test and/or placebo components administered.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidad Complutense de Madridlead
- Bio Nature Essences S.Lcollaborator
Study Sites (1)
Universidad Complutense de Madrid
Madrid, 28005, Spain
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
December 21, 2019
First Posted
January 2, 2020
Study Start
May 1, 2018
Primary Completion
October 25, 2019
Study Completion
December 21, 2019
Last Updated
January 2, 2020
Record last verified: 2019-12